Trials / Completed
CompletedNCT03690999
The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics
Impact of a Prebiotic Supplement on Microbiome, Immune System, and Metabolic Status of Older Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
An individual's immune and metabolic status is coupled to consumed carbohydrates. Complex carbohydrates that are not digested by human enzymes may influence host biology by impacting microbiota composition and function, or act in a yet-unknown microbiota-independent manner. Prebiotics offer a promising safe route to influence host health, possibly via the microbiota. However, it remains largely unknown to what extent immune function and metabolism can be modulated by prebiotics.
Detailed description
The objective of this study is to define the impact of a prebiotic supplement on microbiome, immune system, and metabolic status in older adults. This study will determine the degree to which a prebiotic supplement can 1) regulate immune status and function including reducing chronic, systemic inflammation as assessed by high dimensional immune profiling, 2) alter microbiota composition and function, 3) impact the microbiota metabolites-potential normalizers of metabolic and immune dysfunction, and 4) alter metabolic markers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Placebo product |
| DIETARY_SUPPLEMENT | Prebiotic supplement | Prebiotic supplement |
Timeline
- Start date
- 2019-03-14
- Primary completion
- 2020-11-13
- Completion
- 2020-12-14
- First posted
- 2018-10-01
- Last updated
- 2023-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03690999. Inclusion in this directory is not an endorsement.